New registry checks how well freezing device works for heavy bleeding in daily practice
NCT ID NCT05922657
First seen Jan 05, 2026 · Last updated May 14, 2026 · Updated 15 times
Summary
This study follows 300 women aged 25+ who are scheduled for a Cerene treatment, a freezing therapy for heavy menstrual bleeding. Researchers will track how often women need additional treatment within a year and how their quality of life changes. The goal is to see if results from real-world use match those from earlier clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABNORMAL UTERINE BLEEDING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Axia Women's Health / Rubino OB/GYN Group
RECRUITINGWest Orange, New Jersey, 07052, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Seven Hills Women's Health Centers
RECRUITINGCincinnati, Ohio, 45255, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.